Effects of Lipidation on a Proline-Rich Antibacterial Peptide

The emergence of multidrug-resistant bacteria is a worldwide health problem. Antimicrobial peptides have been recognized as potential alternatives to conventional antibiotics, but still require optimization. The proline-rich antimicrobial peptide Bac7(1-16) is active against only a limited number of...

Full description

Bibliographic Details
Main Authors: Armas, Federica, Di Stasi, Adriana, Mardirossian, Mario, Romani, Antonello A., Benincasa, Monica, Scocchi, Marco
Format: Article
Published: Multidisciplinary Digital Publishing Institute 2021
Online Access:https://hdl.handle.net/1721.1/133210
_version_ 1811093326168850432
author Armas, Federica
Di Stasi, Adriana
Mardirossian, Mario
Romani, Antonello A.
Benincasa, Monica
Scocchi, Marco
author_facet Armas, Federica
Di Stasi, Adriana
Mardirossian, Mario
Romani, Antonello A.
Benincasa, Monica
Scocchi, Marco
author_sort Armas, Federica
collection MIT
description The emergence of multidrug-resistant bacteria is a worldwide health problem. Antimicrobial peptides have been recognized as potential alternatives to conventional antibiotics, but still require optimization. The proline-rich antimicrobial peptide Bac7(1-16) is active against only a limited number of Gram-negative bacteria. It kills bacteria by inhibiting protein synthesis after its internalization, which is mainly supported by the bacterial transporter SbmA. In this study, we tested two different lipidated forms of Bac7(1-16) with the aim of extending its activity against those bacterial species that lack SbmA. We linked a C12-alkyl chain or an ultrashort cationic lipopeptide Lp-I to the C-terminus of Bac7(1-16). Both the lipidated Bac-C12 and Bac-Lp-I forms acquired activity at low micromolar MIC values against several Gram-positive and Gram-negative bacteria. Moreover, unlike Bac7(1-16), Bac-C12, and Bac-Lp-I did not select resistant mutants in <i>E. coli</i> after 14 times of exposure to sub-MIC concentrations of the respective peptide. We demonstrated that the extended spectrum of activity and absence of de novo resistance are likely related to the acquired capability of the peptides to permeabilize cell membranes. These results indicate that C-terminal lipidation of a short proline-rich peptide profoundly alters its function and mode of action and provides useful insights into the design of novel broad-spectrum antibacterial agents.
first_indexed 2024-09-23T15:43:28Z
format Article
id mit-1721.1/133210
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T15:43:28Z
publishDate 2021
publisher Multidisciplinary Digital Publishing Institute
record_format dspace
spelling mit-1721.1/1332102021-11-01T14:36:56Z Effects of Lipidation on a Proline-Rich Antibacterial Peptide Armas, Federica Di Stasi, Adriana Mardirossian, Mario Romani, Antonello A. Benincasa, Monica Scocchi, Marco The emergence of multidrug-resistant bacteria is a worldwide health problem. Antimicrobial peptides have been recognized as potential alternatives to conventional antibiotics, but still require optimization. The proline-rich antimicrobial peptide Bac7(1-16) is active against only a limited number of Gram-negative bacteria. It kills bacteria by inhibiting protein synthesis after its internalization, which is mainly supported by the bacterial transporter SbmA. In this study, we tested two different lipidated forms of Bac7(1-16) with the aim of extending its activity against those bacterial species that lack SbmA. We linked a C12-alkyl chain or an ultrashort cationic lipopeptide Lp-I to the C-terminus of Bac7(1-16). Both the lipidated Bac-C12 and Bac-Lp-I forms acquired activity at low micromolar MIC values against several Gram-positive and Gram-negative bacteria. Moreover, unlike Bac7(1-16), Bac-C12, and Bac-Lp-I did not select resistant mutants in <i>E. coli</i> after 14 times of exposure to sub-MIC concentrations of the respective peptide. We demonstrated that the extended spectrum of activity and absence of de novo resistance are likely related to the acquired capability of the peptides to permeabilize cell membranes. These results indicate that C-terminal lipidation of a short proline-rich peptide profoundly alters its function and mode of action and provides useful insights into the design of novel broad-spectrum antibacterial agents. 2021-10-27T18:49:53Z 2021-10-27T18:49:53Z 2021-07-26 2021-08-06T15:19:20Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/133210 International Journal of Molecular Sciences 22 (15): 7959 (2021) PUBLISHER_CC http://dx.doi.org/10.3390/ijms22157959 Creative Commons Attribution https://creativecommons.org/licenses/by/4.0/ application/pdf Multidisciplinary Digital Publishing Institute Multidisciplinary Digital Publishing Institute
spellingShingle Armas, Federica
Di Stasi, Adriana
Mardirossian, Mario
Romani, Antonello A.
Benincasa, Monica
Scocchi, Marco
Effects of Lipidation on a Proline-Rich Antibacterial Peptide
title Effects of Lipidation on a Proline-Rich Antibacterial Peptide
title_full Effects of Lipidation on a Proline-Rich Antibacterial Peptide
title_fullStr Effects of Lipidation on a Proline-Rich Antibacterial Peptide
title_full_unstemmed Effects of Lipidation on a Proline-Rich Antibacterial Peptide
title_short Effects of Lipidation on a Proline-Rich Antibacterial Peptide
title_sort effects of lipidation on a proline rich antibacterial peptide
url https://hdl.handle.net/1721.1/133210
work_keys_str_mv AT armasfederica effectsoflipidationonaprolinerichantibacterialpeptide
AT distasiadriana effectsoflipidationonaprolinerichantibacterialpeptide
AT mardirossianmario effectsoflipidationonaprolinerichantibacterialpeptide
AT romaniantonelloa effectsoflipidationonaprolinerichantibacterialpeptide
AT benincasamonica effectsoflipidationonaprolinerichantibacterialpeptide
AT scocchimarco effectsoflipidationonaprolinerichantibacterialpeptide